[Knocking down human CD59 gene expression decreased protection to complement-mediated cytolysis]

Area of Science:

• Molecular Biology
• Immunology
• Cancer Research

Background:

• CD59 plays a role in protecting cells from complement-mediated lysis.
• Understanding CD59's function is crucial for cancer immune escape mechanisms.
• Targeting CD59 may offer novel therapeutic strategies for cancer treatment.

Purpose of the Study:

• To construct recombinant vectors expressing small interfering RNA (siRNA) targeting the CD59 gene.
• To establish a stable A2780 ovarian cancer cell line with inhibited CD59 expression.
• To analyze the role of CD59 in protecting against complement-mediated cytolysis.

Main Methods:

• Construction of a pSUPER vector containing a 60 bp shRNA sequence targeting CD59.
• Transfection of A2780 cells with the recombinant plasmid using liposomes.
• Selection of stable cell lines using G418 medium, followed by RT-PCR, Western blot, and dye release assays to assess CD59 expression and function.

Main Results:

• Successful construction of the pSUPER-siRNA vector and establishment of a stable A2780 cell line expressing GFP.
• Significant inhibition of CD59 gene expression at both mRNA and protein levels.
• Demonstrated reduction in CD59's protective effect against complement-mediated cytolysis.

Conclusions:

• The developed siRNA vector effectively and consistently inhibits CD59 expression.
• Reduced CD59 expression diminishes its protective role against complement-mediated cell damage.
• These findings support further investigation into CD59's role in tumor immune evasion and potential therapeutic applications.